|Home | About | Journals | Submit | Contact Us | Français|
Blockade of monoamine transporters by cocaine should not necessarily lead to certain observed consequences of cocaine administration, including increased firing of ventral mesencephalic dopamine neurons and accompanying impulse-stimulated release of dopamine in the forebrain and cortex. Accordingly, we hypothesize that the dopaminergic activating effect of cocaine requires stimulation of dopaminergic neurons by afferents of the ventral tegmental area. We sought to determine if afferents of the ventral tegmental area are activated following cocaine administration. Rats were injected in the ventral tegmental area with retrogradely transported Fluoro-Gold and, after one week, were allowed to self-administer cocaine or saline via jugular catheters for two hours on six consecutive days. Other rats received like amounts of investigator-administered cocaine through jugular catheters. Afterward, the rats were killed and the brains processed immunohistochemically for retrogradely transported tracer and Fos, the protein product of the neuronal activation-associated immediate early gene, c-fos. Forebrain neurons exhibiting both Fos and tracer immunoreactivity were enriched in both cocaine groups relative to the controls only in the globus pallidus and ventral pallidum, which, together, represented a minor part of total forebrain retrogradely labeled neurons. In contrast, both modes of cocaine administration strongly increased double-labeling relative to the controls in the brainstem, specifically in the caudal ventromedial mesencephalon and rostromedial pontine tegmentum. It is concluded that a previously unappreciated activation of pallidal and brainstem afferents may contribute to the modulation of dopaminergic neuronal activity following cocaine administration.
The high abuse liability of the psychostimulant drug cocaine (Johanson and Fischman, 1989) is thought to stem mainly from its capacity to block the re-uptake of dopamine by the dopamine transporter (Koe, 1976; Ritz et al., 1987; Woolverton, 1987; Einhorn et al., 1988; Balster, 1990; Vanover, 1992; Howell and Byrd, 1995; Roberts et al., 1999; Wee and Woolverton, 2004). Indeed, the acute reinforcing and locomotor activating effects of cocaine are linked to sustained increases in extracellular concentrations of dopamine (DA) in structures that are innervated by DA transporter-enriched DAergic projections (Carboni et al., 1989; Staley et al., 1995; Freed et al., 1995), such as the nucleus accumbens and prefrontal cortex (Moghaddam and Bunney, 1989; Kalivas and Duffy, 1990; Maissoneuve et al., 1990; Sorg and Kalivas, 1990). This dopamine overflow, in turn, especially when chronically repeated, leads to long-lasting neuroadaptations (Downs and Eddy, 1932; Kalivas and Duffy, 1990; Kalivas and Stewart, 1991; Hope et al., 1992; Pierce and Kalivas, 1997; White and Kalivas, 1998; McFarland and Kalivas, 2001; Nestler, 2001; Borgland et al., 2004; Bowers et al., 2004; Kelz et al., 2004; Jones and Bonci, 2005; Moran et al., 2005; Olausson et al., 2006; Sun and Rebec, 2006) thought to underlie drug dependence (Koob and Bloom, 1988; Kreek and Koob, 1998; White and Kalivas, 1998; Nestler, 2001; Jones and Bonci, 2005; Shaham and Hope, 2005).
It is pertinent, however, that the effect of cocaine on dopamine turnover is due not to stimulation of the release of dopamine, but, rather, blockade of its re-uptake (refs. cited above). Thus, the resulting increased extracellular concentrations of dopamine might be expected to be offset by the inhibitory effect of dopamine acting at autoreceptors, which, by inactivating dopamine neurons (Bunney et al., 1973; Aghajanian and Bunney, 1977), would tend to reduce rather than increase extracellular dopamine concentrations. In this regard, White and colleagues (Einhorn et al., 1988; White, 1990) reported that the anticipated autoreceptor-mediated inactivation of ventral tegmental dopamine neurons is less complete and more short-lived than expected considering the binding properties of cocaine, which suggests the existence of offsetting mechanisms that maintain the activity of dopaminergic neurons in the presence of cocaine (see also Cameron and Williams, 1994; Shi et al., 2004).
One such mechanism could involve stimulation of the ventral tegmental area (VTA), which contains dopamine neurons that project to the accumbens and prefrontal cortex (Beckstead et al., 1979; Swanson, 1982), by inputs arising in other parts of the brain. Indeed, neurons projecting to the VTA are numerous, occupying many differentiated structures and intervening brain areas aligned along the medial forebrain bundle from the prefrontal cortex to the medulla oblongata (Phillipson, 1979; Geisler and Zahm, 2005). A large proportion of these VTA afferents possess neurotransmitter/modulator substances that excite dopamine neurons (White, 1996; Mathon et al., 2003; Fields et al, 2007), including glutamate (Geisler et al., 2007), neurotensin (Geisler and Zahm, 2006) and cocaine and amphetamine-related transcript (Philpot et al., 2005).
It was with a view to these considerations that the present study was carried out in the rat to determine whether afferents of the VTA are activated by cocaine administration. To accomplish this, VTA-projecting neurons were prelabeled with retrogradely transported Fluoro-Gold (FG) a week prior to when groups of rats began self-administering cocaine or saline or received investigator-administered infusions of cocaine. They were killed for analysis after the sixth consecutive daily self-administration session. Neuronal activation was assessed by immunohistochemical detection of Fos protein, the product of the immediate-early gene, c-fos.
Twenty-seven male Sprague-Dawley rats (Harlan, Indianapolis, IN, USA) weighing 225–250 g at the start of the study were used in accordance with guidelines mandated in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The rats were singly housed on a 12 hr reverse light-dark cycle and given food and water ad libitum. Unless stated otherwise, chemicals were purchased from Sigma (St. Louis, MO).
The rats were deeply anaesthetized by intraperitoneal injections of a cocktail consisting of 45% ketamine (100mg/ml), 35% xylazine (20mg/ml) and 20% saline at a dose of 0.16 ml/100g of body weight. A silastic catheter (20 μl dead volume) was inserted via the external jugular vein into the right atrium of the heart, passed under the skin and fixed in the midscapular region. Immediately after the catheters were implanted, the rats were placed into a Kopf stereotaxic instrument and the retrograde tracer Fluoro-Gold (FG; Fluorochrome, Inc., Englewood, CO; 1% in 0.1M cacodylate buffer, pH 7.4) was injected iontophoretically into the VTA through 1.0 mm filament-containing glass pipettes pulled to tip diameters of 15–20 μm using 1 μA positive pulses (7 s on and 7 s off for 15 minutes). After surgery, the rats were kept warm until they awakened. Subsequently, the catheters were flushed daily with sterile saline to prevent clogging.
Immediately following surgery and daily thereafter the rats were gently handled in order to flush the catheters with saline. One week after surgery, the animals were placed in a self-administration chamber (Med. Associates, St. Albans, VT) and allowed to self-administer cocaine (SAC group; n=9; 500 μg/kg per 30 μl infusion) or saline (SAS group; n=9) for six consecutive days (2h/day, during the dark part of the dark/light cycle) as previously described (Marinelli et al., 2003). Briefly, nose-poking in the active hole delivered an infusion (cocaine or saline) and, for a period of 30 sec, illuminated the hole with an LED light, which in and of itself is reported to stustain a moderate level of responding (Marinelli et al., 2003). Nose poking in the inactive hole had no consequences. Self-administration was regarded as established when nose pokes were significantly more numerous in the active than inactive hole. Rats given investigator-administered infusions of cocaine (YAC group; n=9) were placed in separate chambers located in the same environment as the SAC and SAS rats. These rats received infusions administered by the investigator in numbers and at time intervals reflecting the averages delivered on the same day to the rats in the SAC group. Catheters were to be regarded as having remained patent throughout the study if 200 μl of the ketamine/xylazine mixture could be delivered through them on the last day of the experiment. Thus, rats that did not succumb within 3–5 s following this treatment were to be removed from the study. All of the lines remained open in the present study. Self-administration cages were also equipped with two photocell beams located in the long axis of the cage to monitor locomotor activity.
One and one-half hours after the beginning of the sixth daily self-administration session, the rats were deeply anesthetized and perfused transaortically with buffered (0.1 M Sorensen's phosphate buffer, pH 7.4 - SPB) aldehydes and the brains were sectioned and processed for immunohistochemistry as has been described [see Geisler and Zahm (2005) for details]. Five adjacent series of sections were collected, each representing an entire brain from frontal pole to caudal medulla at intervals of 250 μm. Each series of sections was stored in a separate glass vial at −20°C in a cryoprotectant consisting of SPB containing 30% sucrose and 30% ethylene glycol.
One series of sections from each case was immersed in SPB containing 0.1% Triton X-100 (SPB-t) and a rabbit polyclonal antibody raised against a synthetic peptide corresponding to amino acids 4–17 of human c-Fos at a dilution of 1:5000 (Anti-c-Fos [Ab-5] [4–17] Rabbit pAb, formerly from Oncogene Science, Cambridge MA, now from Calbiochem, San Diego CA). The following day, after thorough rinsing in SPB-t, the sections were immersed in SPB-t containing a biotinylated antibody made in donkey against rabbit IgGs at a dilution of 1:200 (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) for an hour. Afterward, the sections were rinsed in SPB and then immersed in SPB containing avidin-biotin-peroxidase complex (ABC) at a dilution of 1:200 (Vector Laboratories, Burlingame CA) for an hour. After thorough rinsing in SPB, the sections were reacted in 0.025 M Tris buffer (pH 8.0) containing 0.015% 3,3’–diaminobenzidine (DAB), 0.4 % nickel ammonium sulfate and 0.003 % hydrogen peroxide, which generates an insoluble black reaction product.
The sections were then subjected to additional rinsing in SPB and then immersed in SPB-t containing an antibody raised in rabbit against FG and used at a dilution of 1:5000 (Chemicon, Temecula, CA, USA). The following morning the sections were rinsed in SPB-t and immersed for one hour in SPB-t containing a donkey antibody against rabbit IgGs used at a dilution of 1:200 (Jackson). Following further rinsing in SPB the sections were immersed for one hour in SPB containing rabbit peroxidase-anti-peroxidase (PAP) at a dilution of 1:3000 (ICN Biomedicals, Inc., Aurora, OH), after which they were again rinsed thoroughly. Then the sections were immersed for 20–30 min in 0.05 M SPB (pH 7.4) containing 0.05% DAB, 0.04% ammonium chloride, 0.2% β-D-glucose, and 0.0004% glucose oxidase, which generates an insoluble brown reaction product. The sections then were mounted onto gelatin coated slides, dehydrated through a series of ascending concentrations of ethanol, transferred into xylene, and coverslipped with Permount (Fisher, Pittsburgh, PA). Staining for Fos and FG was absent when the relevant primary or secondary antibodies, ABC or PAP reagents were omitted.
Additional sections were prepared to exhibit single labeling for tyrosine hydroxylase (TH)-ir (Chemicon), for the evaluation of FG injection sites, and for double-labeling with Fos-ir and TH-ir or Fos-ir and nitric oxide synthase (NOS)-ir (Sigma), in order to determine if Fos-ir was expressed in dopaminergic and cholinergic neurons, respectively. Protocols to accomplish this were carried out as described above using appropriate second antibodies, except, for Fos/TH double-labeling, the second antibodies were conjugated to fluorescent compounds fluorescein and Texas Red and examined with epifluorescence illumination (Jackson ImmunoResearch Labs). All of the antibodies used in the study have been well characterized by the manufacturers and were evaluated in our hands with appropriate omission controls.
The analysis was carried out with the aid of the MDPlot5 hardware-software platform (Accustage, Shoreview, MN), which was used to generate digitized 2-D representations of the outlines of the sections, ventricles, and major white matter bundles, as well as all FG-ir (retrogradely labeled) and double-labeled (FG-ir plus Fos-ir) neurons. For forebrain, series of 17 consecutive sections spaced at 250 μm intervals beginning at the rostral tip of the accumbens and extending to include the rostral one-third of the lateral hypothalamus were analyzed. The lateral habenula was evaluated in a separate series of sections. For brainstem, similarly spaced series of six sections beginning at the midpoint of the interpeduncular nucleus and extending caudalward to the level of the laterodorsal tegmental nucleus were evaluated. Structures of interest containing retrogradely labeled neurons thus were equivalently represented in all of the evaluated cases. FG-ir and double-labeled neurons were counted with the aid of an MDPlot5 software feature and double-labeled neurons were expressed as percent of retrogradely labeled neurons. Means reflecting 4 cases for each of the three experimental groups (SAS, SAC and YAC) were tested with a one-way ANOVA followed as indicated by Fishers LSD post hoc test.
Four cases with FG injection sites well constrained within the boundaries of the VTA were selected from the SAS, SAC and YAC administration groups for quantitation. The injection sites were located fairly uniformly in the lateral part of the subnucleus parabrachialis pigmentosus at a midrostocaudal level of the VTA (Fig 1).
Consistent with reports cited in the Introduction, FG-labeled descending projections to the VTA were observed in the medial prefrontal cortex, medial and lateral septum, accumbens, ventral parts of the bed nucleus of stria terminalis, ventral pallidum, medial preoptic area, lateral habenula and the lateral preoptic region and its continuation into the lateral hypothalamus. Due to the lateral placement of FG injections in the VTA, retrogradely labeled neurons also were observed consistently in the ventral and medial parts of the globus pallidus (Figs. 2, ,33 and and4).4). Most of the labeling in the forebrain was ipsilateral to the injections, but significant contralateral labeling was present in the preoptic regions and lateral hypothalamus. In the brainstem, retrogradely labeled neurons were abundant on both sides of the brain within and between numerous structures, including the periaqueductal gray, dorsal raphe, pedunculopontine tegmental nucleus, laterodorsal tegmental nucleus, parabrachial nucleus, locus ceruleus, median and paramedian raphe, deep mesencephalic nucleus and the mesopontine reticular formation.
Fos-ir neurons were abundant throughout the entire brain, albeit more so in the brains from the SAC and YAC as compared to SAS groups (manuscript in preparation). Neurons containing both FG-ir and Fos-ir, i.e., double-labeled neurons (Fig. 2), were observed in most structures that project to the VTA. In the forebrain, almost all structures exhibited similar numbers of double-labeled neurons in the three treatment groups (Table 1, Fig. 3). Significantly greater numbers of double-labeled forebrain neurons were observed in the SAC and YAC brains only in the ventral pallidum and globus pallidus (Figs. 2–4). Retrogradely labeled neurons were located predominantly medially in the globus pallidus and sublenticular ventral pallidum (Fig. 4B), but were spread more uniformly through the subcommissural ventral pallidum (Fig. 4A). Double-labeling as a percent of numbers of retrogradely labeled neurons was significantly greater in the globus pallidus and sublenticular, as compared to the subcommissural, part of the ventral pallidum (Table 2).
In contrast to forebrain, double-labeled neurons were enriched throughout the mesencephalon and pons in the brains of rats from the SAC and YAC groups as compared to  brainstem of SAS groups and  the forebrain of SAS, SAC and YAC groups (Table 1). Maximal double-labeling in brainstem coincided with the position of a spot-like aggregation of densely packed Fos-ir neurons observed only in the brains of rats from the SAC and YAC groups (Fig. 5). This dense cluster of Fos-ir neurons was present bilaterally and many neurons within it on both sides of the midline were double-labeled, albeit more so ipsilateral to the injections site (Figs. 5A–E and 6A–D). The rostralmost part of the cluster was embedded in the caudal subnucleus paranigralis of the ventral tegmental area (Fig. S1A and B) just above the medial extremity of the medial lemniscus, although no evidence was found for co-localized Fos-ir and TH-ir (a marker of VTA dopaminergic neurons) in immunoperoxidase (Fig. S1) or immunofluorescence (data not shown) material. The mesopontine cluster of Fos-ir neurons was incrementally larger in successively more caudal sections (Figs. 5A–C and E and 6A–D), turning dorsolateralward to first lie in the ventromedial aspect of the A8 dopaminergic field, and then, leaving the dopamine-rich part of the ventral mesencephalon, in the medial part of the deep mesencephalic reticular formation, and, finally, the rostromedial pontine tegmentum (Figs. 5E and 6C and D and S1C). Double-labeling associated with the dense of the cluster of Fos-ir neurons was densest at its center (* in Fig. 7), somewhat less so in its periphery (** in Fig. 7), and least in the rest of the brainstem.
The conspicuous enrichment of double-labeled neurons occupied a position medial to the pedunculopontine tegmental nucleus (PPTg), although its lateral parts did overlap somewhat with medial parts of the pars dissipata of the PPTg (Fig. 6C and D). While the extent to which double-labeling of FG-ir and cholinergic or glutamatergic PPTg neurons occurred in this zone of overlap was not determined, visibly less double-labeling of FG-ir with Fos-ir was observed there than within the cluster of Fos-ir neurons and its immediate surround (Fig. 7; Table 3). In material from SAC and YAC brains processed to exhibit Fos-ir and NOS-ir, a marker of cholinergic neurons in the PPTg and laterodorsal tegmental nucleus (Sugaya and McKinney, 1994), only occasional double-labels were observed (Fig. S2).
All SAC and SAS rats exhibited reliable self-administration behavior. Throughout the sessions, nose poking in the active hole (paired with an infusion and light cue) was more frequent than nose poking in the inactive hole (Fig. 8A; hole effect: F1, 15 = 213.2, p<0.001; hole x drug effect: F1, 15 = 36.2, p<0.001). SAC and SAS rats did not differ for inactive hole responding. However, nose poking in the active hole was more than double for SAC rats compared with SAS rats (drug effect: F2, 22 = 431, p<0.001; SAS vs SAC and YAC: p<0.001, SAC vs. YAC: n.s). As a result, SAC rats took more than twice as many infusions as SAS rats (Fig. 8B). These numbers were maintained by both groups during the six consecutive daily sessions (Fig. 8C). YAC rats were given infusions in numbers and at time intervals nearly identical to the SAC group (Fig. 8B, C; drug effect: F2, 22 = 40.4, p<0.001; SAS vs. SAC and YAC: p<0.001, SAC vs. YAC, n.s.). The average intake of cocaine over 2h was 21.5 ± 1.7 mg/kg and 21.9 ± 0.4 mg/kg in the SAC and YAC groups, respectively. Horizontal locomotion was more than twice greater for SAC as compared to SAS rats (Fig. 8D; drug effect: F1, 15 = 7.0, p<0.02) and, whereas the locomotion of YAC rats was not measured objectively, it appeared upon visual inspection to be substantially greater than that of SAS rats and comparable to that of SAC rats.
Self-administration and investigator-administered infusions of cocaine increased the numbers of VTA-projecting brainstem neurons co-expressing Fos, the protein product of the immediate early gene c-fos. The peak density of such neurons occupied a neuronal aggregation in the ventromedial mesopontine tegmentum that in single sections appears spot-like, but can be inferred from the information in rostrocaudally ordered series of sections to represent a more or less cone-shaped volume with an apex embedded in the caudal part of the VTA/retrorubral field (RRF) and base situated in the rostromedial pontine tegmentum. Insofar as  no evidence was found for co-localized Fos-ir and TH-ir and  as many or more of the Fos-ir and double-labeled neurons lay outside of the VTA/RRF as in it, it was concluded that the Fos-ir and double-labeled neurons comprise a functional (Fos labeling)-anatomical (FG labeling) entity distinct from the VTA/RRF. With hindsight, a distinct condensation of VTA afferents coinciding with the position of this aggregation of Fos-ir neurons is clearly visible in previous descriptions (e.g., Geisler and Zahm, 2005, figs. 8D, 9C, and 11B and C ), but lacking the Fos-ir neurons as a reference in the earlier paper, the implications of these afferents for psychostimulant effects could not have been surmised. In further support, we have unpublished anterograde tracing data indicating that neurons in this cluster give rise to a robust axonal projection that terminates in the VTA.
In contrast to the brainstem, the numbers of forebrain VTA-projecting neurons that co-expressed Fos-ir were no greater in cocaine self-administering rats and rats that received investigator-administered infusions of cocaine than in those that self-administered saline, except in the pallidum, including the globus pallidus and ventral pallidum, but these activated pallidal neurons are a minor part of the overall descending input to the VTA. Consequently, the present data suggest that afferents ascending from the mesopontine tegmentum provide the predominant activated input to the VTA during cocaine exposure. What, specifically, activates these brainstem VTA afferents remains to be determined.
All of the SAC and SAS rats exhibited consistent and stable self-administration behavior through six daily sessions. They were killed immediately after the sixth session in order to assess the possibility that activated VTA afferents contribute to the actions of cocaine during active operant responding to acquire it. Insofar as the six day time point is but one window into a continuously developing drug response (White and Kalivas, 1998; Nestler, 2001), the Fos-labeling of VTA afferents, as described here, cannot be presumed representative of other time points and may turn out to be an evolving neuroadaption to cocaine.
Cocaine given i.p. at 40 mg/kg produces sporadic seizures in some animals during the second week of daily injections (Kilbey et al., 1979). Insofar as the rats in the present investigation self-administered on average 21.7 mg/kg/day, and i.v. administration is regarded to produce 5–10 times the brain concentrations of i.p. administered cocaine, the possibility must be considered that proconvulsant levels of cocaine were achieved in the brains of some rats in the present investigation, particularly those that received investigator-administered drug (Dworkin et al., 1995). However, no seizures were observed in the present investigation, in which self-administration lasted for only six days and involved numerous small infusions of drug distributed over the course of 2 h. All of the self-administering rats rapidly established similar self-titrated, controlled patterns of self-administration (Yokel, 1987; Pettit and Justice, 1989; 1991; Wise et al., 1995; Ahmed and Koob, 1998), which were maintained during six days. Patterns of neuronal Fos-ir labeling throughout the brains were very consistent across animals in the various treatment groups (manuscript in preparation). Thus, it is concluded that the cocaine-elicited activations of brain reached in the present investigation were fairly consistent across the rats in the SAC and YAC groups and reliably below seizure thresholds.
Rats receiving cocaine infusions were compared with a control group that self-administered saline. The saline-administering rats took about half as many infusions as those nose poking for cocaine, suggesting that i.v. saline paired with a light cue provides at least a moderate level of reinforcement and associated locomotion, as previously shown (Marinelli et al., 2003). While not a perfect control, rats self-infusing saline are regarded as superior to naive controls or rats receiving vehicle injections, due not only to the presumed mild motivation and associated motor activation, noted above, but also to the fact that both they and the cocaine-infused rats, including those that received investigator-administered cocaine, were exposed during testing to similar stimuli accompanying daily removal from the home cage to a separate test chamber. As regards the potential impact of stress, all of the rats used in the present study were subjected daily throughout the course of the study to gentle human handling in conjunction with the flushing of the catheters, in an effort to minimize as well as equalize across groups the effects of handling as a stress variable. In view of this precaution, it is suggested that the consistent trend observed in the present study toward greater numbers of Fos-ir VTA afferents in rats receiving investigator- as compared to self-administered cocaine is not due to the handling associated with investigator administration of drug (Barrot et al., 1999), but may instead reflect the superimposition of passive drug administration stress on the drug response (Mutschler and Miczek, 1998; Marinelli, 2007). There also may be some concern that cues associated with investigator-administration of cocaine render it a signaled rather than truly noncontingent delivery of drug and thus possibly possessing some rewarding quality (Browman et al., 1998). Consequently, the observed Fos-labeling, which did not differ between the investigator- and self-administered treatment groups, seems most likely to have been due strictly to the pharmacological actions of cocaine, but an effect of the cognitive-motivational state of the rats cannot be entirely ruled out.
In another recent study (Colussi-Mas et al., 2007), D-amphetamine was administered acutely by subcutaneous injection to drug-naive rats and produced a generalized increase in Fos-labeling in VTA afferents, including within numerous forebrain structures. Although no mention was made in that report of a dense spot-like aggregation of Fos-ir VTA afferents located in the ventromedial mesopontine tegmentum, as was observed in the present study, we have observed such a pattern of Fos-ir neurons in rats given subcutaneous injections of methamphetamine at 10 mg/kg (unpublished results), suggesting that this Fos expression pattern generalizes across different psychostimulant drugs and further suggesting that it is pharmacologically rather than movivationally driven. Apart from the issue of this brainstem cluster of Fos-ir neurons, the stress of a first psychostimulant drug exposure, distinct pharmacological action of cocaine as compared to D-amphetamine, different pharmacokinetics of catheter as compared to s.c. delivered drug, titration of cocaine dose by the self-administering rats themselves and, perhaps, other as yet unidentified factors may account for the differences in Fos-labeling of forebrain afferents of the VTA following administration of D-amphetamine (Colussi-Mas et al., 2007) and cocaine (present study).
In order to uniformly sample from VTA-projecting neurons, FG injections were done in all rats using, to the extent possible, identical pipette tips, current parameters and stereotaxic coordinates, which led to a potential shortcoming of the study, i.e., that the coordinates employed produced FG injections mainly in the lateral part of the VTA. However, our unpublished anterograde tracing study revealed dense axonal projections from the Fos-ir, VTA-labeled neuron cluster to lateral and medial parts of the VTA, suggesting that the medial VTA is also related by connections to the aggregation of Fos-ir neurons observed following cocaine administration.
Insofar as retrograde labeling by FG is complete a day or two after FG is injected (Zahm et al., 2001), FG-ir should have “pre-labeled” similar numbers of VTA afferents in the three treatment groups. That this was achieved is confirmed by Table 1, which shows statistically indistinguishable numbers of retrogradely labeled neurons in forebrain and brainstem in the four evaluated cases from each of the three treatment groups. This being so, it can be argued that double-labeled neurons could simply have been counted, rather than calculating what percent of retrogradely labeled neurons they comprised. Indeed, simple counts of double-labeled neurons, despite exhibiting more data scatter than the percentages, did reveal statistically valid increases in the brainstem and pallidum, but not in the rest of the forebrain, following cocaine administration (Table 1).
The present data reveal that the administration of cocaine is accompanied by activation of VTA afferents residing mainly in the mesopontine tegmentum and, to a lesser extent, pallidum. In interpreting this finding, the following points need to be kept in mind.  Failure to detect Fos-ir in a neuron does not necessarily mean that it has not been activated.  Increased activity of DA neurons following psychostimulant administration may be due to the removal of tonic inhibitory influences, which would not be revealed by the detection of Fos-ir.  Increased Fos expression could signal increased activity in inhibitory afferents of the VTA. Thus, it is apparent that the extent to which the observed activation of afferents causes an excitation of DAergic neurons was not addressed in the present study, nor necessarily predictable from the data.
With these caveats in mind, a number of points can be made, nonetheless, regarding potential roles for VTA afferents in the control of DA neuron activity following cocaine administration. Ventral pallidal afferents of the VTA, which are known to contact DAergic neurons (Groenewegen et al., 1994) were classically regarded as GABAergic (Kalivas et al., 1993) and, thus, upon activation, might be expected to inhibit DAergic neurons. Indeed, Floresco et al. (2003) have reported that inhibition of pallidal afferents by infusion of a muscimol/baclofen coctail selectively increases the population activity of DA neurons in the VTA. However, it is likely that VP neurons also target GABAergic neurons residing in the VTA (e.g., Carr and Sesack, 2000) or occupying other structures that projecting to the VTA (Geisler and Zahm, 2005), either of which might then disinhibit DA neurons. Also noteworthy in this regard is the recent observation that 35% of ventral pallidal neurons projecting to the VTA is glutamatergic (Geisler et al., 2007). Consistent with the cautionary considerations listed above, such potential disinhibitory and excitatory actions may have important physiological roles that would not necessarily be revealed within a milieu of neurons profoundly silenced by muscimol/baclofen infused into the VP.
In view of the robust cocaine-elicited Fos expression observed in numerous brainstem afferents of the VTA located in the caudal ventromedial mesencephalon and rostromedial pons, it is interesting to recollect that a “midbrain locomotor region” (MLR), i.e., a district occupied by sites where electrical stimulations elicit coordinated locomotor movements in anesthetized cats (Shik et al., 1966) and rats (Coles et al., 1983), is present at the same brainstem levels. This coincidence calls to mind the possibility that the Fos-activated neurons detected in this study might belong to the MLR and so exert the acute locomotor activating effects of cocaine directly. In considering this possibility, it is pertinent that the MLR was first reported to coincide with the cuneiform nucleus (Shik et al., 1966) and then the pedunculopontine tegmental (PPTg) nucleus (Garcia-Rill, 1985), both of which lie well lateral to the striking condensation of VTA afferents exhibiting cocaine-elicited Fos-expression described herein. However, in an incisive review of the literature, Inglis and Winn (1995) later maintained that neither of these structures represents an accurate neuroanatomical correlate of the MLR. To the contrary, as studies continued to promulgate, more diverse and complex movements were observed following stimulations in an increasingly broad expanse of mesopontine sites. Consequently, while the possibility cannot be excluded at present that Fos-activated VTA afferents contribute directly to the acute locomotor activating effects of cocaine via local mechanisms exerted within the MLR or an expanded conceptualization of it, the connections with the VTA seem more likely to be critical in this regard.
Any suggestions regarding the phenotype(s) or synaptic relationships of the densely packed cocaine-activated brainstem afferents of the VTA must also be regarded as speculative. We do know that these neurons are not DAergic (present results). Nor is their prominently ventromedial position consistent with much overlap with the cholinergic/glutamatergic PPTg-laterodorsal tegmental (LDTg) nuclear complex, although such overlap clearly occurs to a limited extent in the ventromedial, so-called dissipated parts, of the PPTg and less so in its other parts (Table 3). The LDTg, reported to provide the major cholinergic projection to the ventral tegmental area (Oakman et al., 1995), contained numerous retrogradely labeled neurons, but only moderate double-labeling (Table 3). Accordingly, we also saw little double-labeling of Fos-ir in NOS-ir (cholinergic) neurons in the PPTg or LDTg (Fig. S2). It is unclear how the present functional-anatomical data will ultimately reconcile with the results of functional studies identifying the LTDg specifically as critical to the capacity of VTA DA neurons to burst fire (Lodge and Grace, 2006) and the compact part of the PPTg as critical to stimulating such burst firing (Floresco et al., 2003).
The glutamatergic phenotype also seems not to be strongly represented in VTA-projecting neurons occupying the ventromedial mesopontine tegmentum (Geisler et al., 2007, see fig. 6J), which leaves GABA as an obvious compound of interest, but with essentially no empirical evidence for or against. Thus, pending further investigation, it may be imprudent to speculate further about whether the Fos-activation of VTA afferents might indicate facilitation or opposition to previously described mechanisms (e.g., Cameron and Williams, 1995; Marinelli et al., 2003; Shi et al., 2004; Liu et al., 2005) thought to contribute to maintaining the activity of VTA DA neurons against autoreceptor-mediated inhibition in the presence of cocaine. Nonetheless, to the extent that repeated c-fos expression has been associated with the development of compensatory neuroadaptations to cocaine in other brain structures (e.g., Hope et al., 1992; Kelz et al., 1999), it seems quite reasonable to entertain the possibility that cocaine-activated Fos-ir afferents of the VTA may be a substrate for additional neuroadaptations that could directly influence the responses of VTA DA neurons during cocaine-seeking, withdrawal and relapse.
Figure S1: Micrographs illustrating the formation of densely packed Fos-immunoreactive (-ir) neurons in sections processed to exhibit tyrosine hydroxylase (TH)-ir. The rostral part of the Fos-ir formation is enmeshed in TH-ir neurons, dendrites and axons in the caudal part of the subnucleus paranigralis (PN) of the ventral tegmental area (box in A, enlarged in B). Note the densely black Fos-ir nuclei among the brown TH-ir structures in B. At a more caudal level, the Fos-ir formation (arrows in C) lies caudal to the VTA and retrorubral field (RRF) and is not associated with TH-ir structures. Panel C is enlargement of the box in the inset. Additional abbreviations: cp – cerebral peduncle; IPN – interpeduncular nucleus; ml – medial lemniscus. Scale bars: A and C - 1 mm; B - 100μm; inset - 1mm.
Figure S2: Micrographs illustrating the cholinergic neurons (revealed with brown immunostaining against nitric oxide synthase) of the pedunculopontine tegmental nucleus (PPTg), which comprises compact (cPPTg) and dissipated (dPPTg) parts, and laterodorsal tegmental nucleus (LDTg), which contained numerous retrogradely labeled neurons in the present study and was previously reported to provide the major cholinergic projection to the ventral tegmental area (Oakman et al., 1995), in relation to Fos-ir structures (black punctate immunostaining) following the sixth consecutive daily exposre to cocaine. The enlargement of the box in A, shown in B, reveals little co-localization of Fos-ir in cholinergic neurons, despite the dense accumulation of Fos-ir nuclei among them. A couple double-labeled neurons are indicated by arrows. Fewer Fos-ir nuclei are co-distributed with the cPPTg and dPPTg, which, consistent with all parts of the PPTg and LDTg evaluated in this study, also exhibited little colocalization of Fos-ir and nitric oxide synthase-ir. Additional abbreviations: Aq – cerebral aqueduct; mlf – medial longitudinal fasciculus. Scale bars: A - 1mm; B - 100 μm.
The authors gratefully acknowledge the expert technical assistance of Jennifer Jackolin and Lindsay Cotterly. The work was supported by USPHS grants NIH NS-23805 and DA-15207 (DSZ), DA-020654 (MM) and DA-016662 (GEM).
Disclosure/Conflict of Interest:
The authors declare that, except for income received from their primary employer, no financial support or compensation has been received from any individual or corporate entity over the past three years for research or professional service and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.
Notice: Supplementary information is available at the Neuropsychopharmacology website.